scholarly journals Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?

2015 ◽  
Vol 18 (8) ◽  
pp. 770-779 ◽  
Author(s):  
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Gene Expression Profiling ◽  
Expression Profiling ◽  
Working Group ◽  
Treatment Decisions ◽  
Oncotype Dx ◽  
Tumor Gene Expression ◽  
Tumor Gene

Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers

2015 ◽  
Vol 11 (4) ◽  
pp. 273-277 ◽  
Author(s):  
Megan C. Roberts ◽  
Stacie B. Dusetzina
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Clinical Practice ◽  
Gene Expression Profiling ◽  
Expression Profiling ◽  
Genomic Test ◽  
Tumor Gene Expression ◽  
Tumor Gene ◽  
Over Time ◽  
Out Of Pocket Costs

Gene expression profiling has diffused into clinical practice. Reimbursements by insurers have increased, and average out-of-pocket costs to patients have decreased, seemingly driven by improved coverage for testing over time.

scholarly journals Patients’ perceptions of gene expression profiling in breast cancer treatment decisions

2014 ◽  
Vol 21 (2) ◽  
pp. 203 ◽  
Author(s):  
Y. Bombard ◽  
L. Rozmovits ◽  
M.E. Trudeau ◽  
N.B. Leighl ◽  
K. Deal ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Cancer Treatment ◽  
Gene Expression Profiling ◽  
Expression Profiling ◽  
Treatment Decisions ◽  
Breast Cancer Treatment
Sign in / Sign up

Export Citation Format

Share Document